Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682197 · ClinicalTrials.gov registry record · NA
Cereset Research In Healthcare Workers During COVID-19
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT04682197 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 144 participants.
The verdict
NCT04682197, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of Cereset Research to improve the symptoms of stress in healthcare workers in an open label, waitlist controlled pilot clinical trial, during the period of COVID-19.
Interventions
- DEVICE Cereset Research
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2021-12-14 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04682197
The ClinicalTrials.gov registry entry for NCT04682197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cereset Research is the first listed.
NCT04682197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04682197 about?
NCT04682197 is a clinical study titled "Cereset Research In Healthcare Workers During COVID-19". The purpose of this study is to evaluate the use of Cereset Research to improve the symptoms of stress in healthcare workers in an open label, waitlist controlled pilot clinical trial, during the period of COVID-19.
What is the current status of trial NCT04682197?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2021-12-14. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT04682197?
The interventions under investigation include: Cereset Research (DEVICE).
Who is sponsoring clinical trial NCT04682197?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.